• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉粥样硬化性肾动脉狭窄与血管重建术

Atherosclerotic renal artery stenosis and revascularization.

作者信息

Choi Sharon S

机构信息

Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA.

出版信息

Expert Rev Cardiovasc Ther. 2014 Dec;12(12):1419-25. doi: 10.1586/14779072.2014.977258. Epub 2014 Nov 5.

DOI:10.1586/14779072.2014.977258
PMID:25370342
Abstract

Atherosclerotic renovascular disease is the most common cause of secondary hypertension. The patients with renovascular disease are at increased risk for adverse cardiac outcomes. Recent trials comparing medical therapy alone to medical therapy with stenting are flawed, but lay to rest any existing debate that unselected revascularization is unwarranted; however, revascularization may be appropriate in high-risk populations. Defining an appropriate population for revascularization is an area of ongoing study. Furthermore, delivery of optimal medical therapy in this population is inadequate. This review describes recent developments in renal artery revascularization.

摘要

动脉粥样硬化性肾血管疾病是继发性高血压最常见的病因。肾血管疾病患者发生不良心脏结局的风险增加。最近比较单纯药物治疗与药物治疗联合支架置入的试验存在缺陷,但平息了关于未经选择的血运重建是否必要的现有争论;然而,血运重建可能适用于高危人群。确定合适的血运重建人群是一个正在进行研究的领域。此外,在这一人群中提供最佳药物治疗并不充分。本综述描述了肾动脉血运重建的最新进展。

相似文献

1
Atherosclerotic renal artery stenosis and revascularization.动脉粥样硬化性肾动脉狭窄与血管重建术
Expert Rev Cardiovasc Ther. 2014 Dec;12(12):1419-25. doi: 10.1586/14779072.2014.977258. Epub 2014 Nov 5.
2
[Effectiveness of percutaneous transluminal renal artery stenting in treating atherosclerotic renal artery stenosis].经皮腔内肾动脉支架置入术治疗动脉粥样硬化性肾动脉狭窄的疗效
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2010 Sep;24(9):1037-40.
3
[Atherosclerotic renal artery stenosis].[动脉粥样硬化性肾动脉狭窄]
MMW Fortschr Med. 2002 Mar 28;144(13):31-3.
4
[Determinants of therapeutical success of percutaneous transluminal renal angioplasty in patients with hypertension caused by atherosclerotic renal artery stenosis].[经皮腔内肾血管成形术治疗动脉粥样硬化性肾动脉狭窄所致高血压患者治疗成功的决定因素]
Pol Arch Med Wewn. 2006 Feb;115(2):99-104.
5
Renovascular hypertension: diagnostic and therapeutic challenges.肾血管性高血压:诊断与治疗挑战
JBR-BTR. 2004 Jan-Feb;87(1):32-5.
6
Outcomes of renal artery angioplasty and stenting using low-profile systems.
J Vasc Surg. 2005 Jan;41(1):46-52. doi: 10.1016/j.jvs.2004.10.027.
7
From the 1990s to CORAL (Cardiovascular Outcomes in Renal Atherosclerotic Lesions) trial results and beyond: does stenting have a role in ischemic nephropathy?从 20 世纪 90 年代到 CORAL(肾动脉粥样硬化病变中的心血管结局)试验结果及以后:支架置入术在缺血性肾病中有作用吗?
Am J Kidney Dis. 2015 Apr;65(4):611-22. doi: 10.1053/j.ajkd.2014.11.026. Epub 2015 Jan 31.
8
Ten-year experience with renal artery in-stent stenosis.肾动脉支架内狭窄的十年经验。
J Vasc Surg. 2011 Apr;53(4):1026-31. doi: 10.1016/j.jvs.2010.10.092. Epub 2011 Jan 7.
9
Renal artery stenosis: a common, treatable cause of renal failure?肾动脉狭窄:肾衰竭常见的可治疗病因?
Annu Rev Med. 2001;52:421-42. doi: 10.1146/annurev.med.52.1.421.
10
Issues related to renal artery angioplasty and stenting.与肾动脉血管成形术和支架置入术相关的问题。
Vascular. 2017 Dec;25(6):618-628. doi: 10.1177/1708538116677654. Epub 2017 Aug 7.

引用本文的文献

1
Long-term outcomes of percutaneous transluminal renal artery intervention: a retrospective study at a single center.经皮腔内肾动脉介入治疗的长期结局:一项单中心回顾性研究
Clin Hypertens. 2024 Aug 1;30(1):21. doi: 10.1186/s40885-024-00282-9.
2
Renal artery revascularization using the inferior mesenteric artery as an inflow source with a long-term follow-up.以肠系膜下动脉作为流入源的肾动脉血运重建及长期随访
J Vasc Surg Cases Innov Tech. 2021 Mar 2;7(2):223-225. doi: 10.1016/j.jvscit.2021.02.010. eCollection 2021 Jun.
3
Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease.
系统生物聚合物递送血管内皮生长因子促进实验性血管性疾病的治疗性血管生成。
Kidney Int. 2018 Apr;93(4):842-854. doi: 10.1016/j.kint.2017.09.029. Epub 2017 Dec 19.
4
Multimarker assessment for the prediction of renal function improvement after percutaneous revascularization for renal artery stenosis.多标志物评估对预测经皮肾动脉狭窄血管重建术后肾功能改善的作用
Cardiovasc Diagn Ther. 2016 Jun;6(3):221-33. doi: 10.21037/cdt.2016.03.01.